Table 1.

Dosing cohorts

Cohort	n	Peginesatide Starting Dose	Dosing Frequency	Route of Administration
A	45	0.05 mg/kg	Q4W	SC
B	15	0.075 mg/kg	Q4W	SC
C	15	0.025 mg/kg	Q4W	SC
D	15	0.05 mg/kg	Q4W	IV
E	15	0.025 mg/kg	Q2W	SCa
F	4	0.0375 mg/kg	Q2W	SC
G	15	4.0 mg	Q4W	SC
H	15	3.0 mg	Q4W	SC

Q4W, every 4 weeks; SC, subcutaneous; IV, intravenous; Q2W, every 2 weeks.

^aBecause of dosing errors, two patients received their peginesatide doses via the intravenous route rather than the subcutaneous route.